Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 289

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Cancer‐associated fibroblast and M 2 macrophage markers together predict outcome in colorectal cancer patients

Open access
Herrera, Mercedes, Herrera, Alberto, Domínguez, Gemma, Silva, Javier, García, Vanesa, García, José M., Gómez, Irene, Soldevilla, Beatriz, Muñoz, Concepción, Provencio, Mariano, Campos‐Martin, Yolanda, García de Herreros, Antonio, Casal, Ignacio, Bonilla, Félix, Peña, Cristina·2013·Cancer Science

Abstract

Tumor epithelial cells within a tumor coexist with a complex microenvironment in which a variety of interactions between its various components determine the behavior of the primary tumors. Cancer‐associated fibroblasts (CAF) and M 2 macrophages, characterized by high expression of different markers, including α‐SMA, FSP 1 and FAP, or CD 163 and DCSIGN, respectively, are involved in the malignancy of different tumors. In the present study, expression of the above markers in CAF and M 2 macrophages was analyzed using RT‐PCR and immunohistochemistry in the normal mucosa and tumor tissue from a cohort of 289 colorectal cancer patients. Expression of CAF and M 2 markers is associated with the clinical outcome of colorectal cancer patients. Moreover, the combination of CAF and M 2 markers identifies three groups of patients with clear differences in the progression of the disease. This combined variable could be a decisive factor in the survival of advanced‐stage patients. Taken together, these analyses demonstrate the prognostic involvement of interrelationships between DCSIGN, CD 163, α‐SMA, FSP 1 and FAP markers in the survival of colon cancer patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/cas.12096

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Cited by

See all 289

Metadata

Authors
Herrera, M., Herrera, A., Domínguez, G., Silva, J., García, V., García, J. M., Gómez, I., Soldevilla, B., Muñoz, C., Provencio, M., Campos‐Martin, Y., García de Herreros, A., Casal, I., Bonilla, F., & Peña, C.
Venue
Cancer Science
Publisher
Wiley
Published
2013-02-21
Volume
104
Issue
4
Pages
437-444
ISSN
  • 1347-9032 (ISSN-L)
  • 1349-7006
OpenAlex
W2061581062
Cited by
289
References
27
FWCI
7.87
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cancer‐associated fibroblast and M 2 macrophage markers together predict outcome in colorectal cancer patients. https://app.cochat.ai/papers/10.1111/cas.12096
The paper
Herrera, M., Herrera, A., Domínguez, G., Silva, J., García, V., García, J. M., Gómez, I., Soldevilla, B., Muñoz, C., Provencio, M., Campos‐Martin, Y., García de Herreros, A., Casal, I., Bonilla, F., & Peña, C. (2013). Cancer‐associated fibroblast and M 2 macrophage markers together predict outcome in colorectal cancer patients. Cancer Science. https://doi.org/10.1111/cas.12096

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.